Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Central nervous system control of food intake

Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · see citing works

A Potential Decline in Life Expectancy in the United States in the 21st Century

Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612 · see citing works

Long-term mortality after gastric bypass surgery

Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572 · see citing works

Gut hormone PYY3-36 physiologically inhibits food intake

Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351 · see citing works

The human orbitofrontal cortex: linking reward to hedonic experience

Kringelbach, M. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1747 · Cited by 2,180 · see citing works

A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · see citing works

A Potential Decline in Life Expectancy in the United States in the 21st Century

Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J. E., Carnes, B. A., Brody, J. A., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944 · see citing works

Glucagon-like peptide-1 7–36: a physiological incretin in man

Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · see citing works

Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate

Olney, J. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,885 · see citing works

Inhibition of Food Intake in Obese Subjects by Peptide YY _3–36

Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · see citing works

Meta-Analysis: Surgical Treatment of Obesity

Maggard, M. A., Shugarman, L. R., Suttorp, M. J., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W., Hilton, L. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567 · see citing works

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2004) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,551 · see citing works

Hypothalamic CART is a new anorectic peptide regulated by leptin

Kristensen, P. L., Judge, M. E., Thim, L., Ribel, U., Christjansen, K. N., Wulff, B. S., Clausen, J. T., Jensen, P. B., Madsen, O. D., Vrang, N., et al. (1998) · Nature · doi:10.1038/29993 · Cited by 1,282 · see citing works

NEUROPEPTIDE Y AND HUMAN PANCREATIC POLYPEPTIDE STIMULATE FEEDING BEHAVIOR IN RATS

Clark, J. T., Kalra, P. S., Crowley, W. R., & Kalra, S. P. (1984) · Endocrinology · doi:10.1210/endo-115-1-427 · Cited by 1,276 · see citing works

Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study

Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163 · see citing works

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1355 · Cited by 1,129 · see citing works

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124 · see citing works

Human distribution and release of a putative new gut hormone, peptide YY

Adrian, T. E., Ferri, G., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., & Bloom, S. R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90211-2 · Cited by 1,064 · see citing works

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057 · see citing works

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., Kim, D. D., & Dunayevich, E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60888-4 · Cited by 1,036 · see citing works

Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

Roux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000183349.16877.84 · Cited by 985 · see citing works

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 916 · see citing works

Antidiabetogenic effect of glucagon-like peptide-1 (7–36)amide in normal subjects and patients with diabetes mellitus

Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868 · see citing works

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Zinman, B., Gerich, J., Buse, J. B., Lewin, A., Schwartz, S., Raskin, P., Hale, P. M., Zdravkovic, M., Blonde, L., & the LEAD-4 Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-2124 · Cited by 848 · see citing works

Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)

Marre, M., Shaw, J. E., Brändle, M., Bebakar, W. M. W., Kamaruddin, N. A., Strand, J., Zdravkovic, M. D., Thi, T. D. L., Colagiuri, S., & on behalf of the LEAD‐1 SU study group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02666.x · Cited by 814 · see citing works

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · cited 1× · see citing works

Leptin Regulates Striatal Regions and Human Eating Behavior

Farooqi, I. S., Bullmore, E., Keogh, J., Gillard, J., O'Rahilly, S., & Fletcher, P. C. (2007) · Science · doi:10.1126/science.1144599 · Cited by 622 · see citing works

A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans

Verdich, C., Flint, A., Gutzwiller, J., Näslund, E. B., Beglinger, C., Hellström, P. M., Long, S. J., Morgan, L., Holst, J. J., & Astrup, A. V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7877 · Cited by 600 · see citing works

The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway

Abbott, C. R., Monteiro, M. P., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., Ghatei, M. A., & Bloom, S. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.011 · Cited by 599 · see citing works

<i>Gpr40</i> Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion

Edfalk, S., Steneberg, P., & Edlund, H. (2008) · Diabetes · doi:10.2337/db08-0307 · Cited by 587 · see citing works

A C-Terminal Fragment of Agouti-Related Protein Increases Feeding and Antagonizes the Effect of Alpha-Melanocyte Stimulating Hormone<i>in Vivo</i>

Rossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.6332 · Cited by 576 · cited 1× · see citing works

Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor

Thorens, B., Porret, A., Bühler, L. H., Deng, S., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 552 · see citing works

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

Willms, B., Werner, J., Holst, J. J., Orskov, C., Creutzfeldt, W., & Nauck, M. A. (1996) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.81.1.8550773 · Cited by 502 · see citing works

PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans

Batterham, R. L., Ffytche, D. H., Rosenthal, J., Zelaya, F. O., Barker, G. J., Withers, D. J., & Williams, S. (2007) · Nature · doi:10.1038/nature06212 · Cited by 474 · see citing works

Recent advances in understanding leptin signaling and leptin resistance

Morris, D. L., & Rui, L. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00274.2009 · Cited by 467 · see citing works

Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences

Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450 · see citing works

The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats

Koda, S., Date, Y., Murakami, N., Shimbara, T., Hanada, T., Toshinai, K., Niijima, A., Furuya, M., Inomata, N., Osuye, K., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1266 · Cited by 431 · see citing works

GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell

Lauffer, L. M., Iakoubov, R., & Brubaker, P. L. (2009) · Diabetes · doi:10.2337/db08-1237 · Cited by 400 · see citing works

A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release

Chu, Z., Carroll, C., Alfonso, J., Gutierrez, V., He, H., Lucman, A., Pedraza, M., Mondala, H., Gao, H., Bagnol, D., et al. (2008) · Endocrinology · doi:10.1210/en.2007-0966 · Cited by 387 · see citing works

Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat

LEIBOWITZ, S. F., Hammer, N. J., & Chang, K. (1981) · Physiology & Behavior · doi:10.1016/0031-9384(81)90366-8 · Cited by 384 · see citing works

Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion

Stanley, B. G., Daniel, D., Chin, A. S., & LEIBOWITZ, S. F. (1985) · Peptides · doi:10.1016/0196-9781(85)90452-8 · Cited by 383 · see citing works

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

Baggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.063 · Cited by 372 · see citing works

Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively

Neary, N. M., Small, C. J., Druce, M. R., Park, A. J., Ellis, S. M., Semjonous, N. M., Dakin, C. L., Filipsson, K., Wang, F., Kent, A. S., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0237 · Cited by 371 · see citing works

Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36

Grandt, D., Schimiczek, M., Beglinger, C., Layer, P., Goebell, H., Eysselein, V. E., & Reeve, J. R. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90204-6 · Cited by 363 · see citing works

Effect of Peptide YY3–36 on Food Intake in Humans

Degen, L. P., Oesch, S., Casanova, M., Graf, S., Ketterer, S., Drewe, J., & Beglinger, C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.001 · Cited by 363 · see citing works

A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7-36) Amide on Ad Libitum Energy Intake in Humans

Verdich, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4382 · Cited by 340 · see citing works

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety

Borg, C.-M., le Roux, C. W., Ghatei, M. A., Bloom, S. R., Patel, A. G., & Aylwin, S. J. B. (2006) · British journal of surgery · doi:10.1002/bjs.5227 · Cited by 318 · see citing works

Central Administration of Glucagon-Like Peptide-1 Activates Hypothalamic Neuroendocrine Neurons in the Rat

Larsen, P. J., Tang‐Christensen, M., & Jessop, D. S. (1997) · Endocrinology · doi:10.1210/endo.138.10.5270 · Cited by 316 · see citing works

Weight Regain in U.S. Adults Who Experienced Substantial Weight Loss, 1999–2002

Weiss, E. C., Galuska, D. A., Kettel Khan, L., Gillespie, C., & Serdula, M. K. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.02.040 · Cited by 307 · see citing works

Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat

Horst, G. J. T., Boer, P. D., Luiten, P. G. M., & van Willigen, J. D. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90441-7 · Cited by 296 · see citing works

The role of gastrointestinal vagal afferents in the control of food intake: current prospects

Schwartz, G. J. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00464-0 · Cited by 294 · see citing works

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230))

Zinman, B., Gerich, J. E., Buse, J. B., Lewin, A., Schwartz, S. E., Raskin, P., Hale, P. M., Zdravkovic, M. D., & Blonde, L. (2010) · Diabetes Care · Cited by 290 · see citing works

Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice

Kanatani, A., Mashiko, S., Murai, N., Sugimoto, N., Itô, J., Fukuroda, T., Fukami, T., Morin, N. R., MacNeil, D. J., der Ploeg, L. H. T. V., et al. (2000) · Endocrinology · doi:10.1210/endo.141.3.7387 · Cited by 250 · see citing works

Orexin Signaling in the Ventral Tegmental Area Is Required for High-Fat Appetite Induced by Opioid Stimulation of the Nucleus Accumbens

Zheng, H., Patterson, L. M., & Berthoud, H.-R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3542-07.2007 · Cited by 248 · see citing works

Effects of PYY1–36and PYY3–36on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects

Sloth, B., Holst, J. J., Flint, A., Gregersen, N. T., & Astrup, A. V. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00450.2006 · Cited by 243 · see citing works

Small-molecule agonists for the glucagon-like peptide 1 receptor

Knudsen, L. B., Kiel, D., Teng, M., Behrens, C., Bhumralkar, D., Kodra, J. T., Holst, J. J., Jeppesen, C. B., Johnson, M. D., de Jong, J. C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605701104 · Cited by 232 · see citing works

Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes

Green, B. D., Flatt, P. R., & Bailey, C. J. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.024 · Cited by 225 · see citing works

Long‐term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over‐weight metformin‐treated patients with type 2 diabetes mellitus

Ratner, R. E., Maggs, D., Nielsen, L. L., Stonehouse, A. H., Poon, T., Zhang, B., Bicsak, T. A., Brodows, R. G., & Kim, D. D. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00589.x · Cited by 217 · see citing works

Amygdalo-Hypothalamic Circuit Allows Learned Cues to Override Satiety and Promote Eating

Petrovich, G. D., Setlow, B., Holland, P. C., & Gallagher, M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08748.2002 · Cited by 205 · see citing works

Descending pathways from hypothalamus to dorsal motor vagus and ambiguus nuclei in the rat

Horst, G. J. T., Luiten, P., & Kuipers, F. (1984) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(84)90008-0 · Cited by 182 · see citing works

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus.

Shughrue, P. J., Lane, M. V., & Merchenthaler, I. J. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895391 · Cited by 175 · see citing works

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db / db mice

Chen, D., Liao, J., Li, N., Zhou, C., Liu, Q., Wang, G., Zhang, R., Zhang, S., Lin, L., Chen, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610173104 · Cited by 171 · see citing works

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

Gantz, I., Erondu, N., Mallick, M., Musser, B., Krishna, R., Tanaka, W. K., Snyder, K., Stevens, C., Stroh, M. A., Zhu, H., et al. (2007) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2006-1806 · Cited by 163 · see citing works

Gastrointestinal targets of appetite regulation in humans

Delzenne, N. M., Blundell, J. E., Brouns, F. J. P. H., Cunningham, K., de Graaf, K. C., Erkner, A., Lluch, A., Mars, M., Peters, H. P. F., & Westerterp‐Plantenga, M. S. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00707.x · Cited by 162 · see citing works

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects

Näslund, E. B., King, N. A., Mansten, S., Adner, N., Holst, J. J., Gutniak, M., & Hellström, P. M. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20031064 · Cited by 160 · see citing works

Evidence of an Orexigenic Role for Cocaine- and Amphetamine-Regulated Transcript after Administration into Discrete Hypothalamic Nuclei

Abbott, C. R., Rossi, M., Wren, A., Murphy, K. G., Kennedy, A. R., Stanley, S. A., Zollner, A. N., Morgan, D. G. A., Morgan, I., Ghatei, M. A., et al. (2001) · Endocrinology · doi:10.1210/endo.142.8.8304 · Cited by 158 · see citing works

Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans

Pannacciulli, N., Le, D. S. N. T., Salbe, A. D., Chen, K., Reiman, E. M., Tataranni, P. A., & Krakoff, J. A. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.12.035 · Cited by 154 · see citing works

Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials

Hutton, B., & Fergusson, D. A. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1461 · Cited by 149 · see citing works

Energy Expenditure, Satiety, and Plasma Ghrelin, Glucagon-Like Peptide 1, and Peptide Tyrosine-Tyrosine Concentrations following a Single High-Protein Lunch

Smeets, A. J. P. G., Soenen, S., Luscombe‐Marsh, N. D., Ueland, Ø., & Westerterp‐Plantenga, M. S. (2008) · Journal of Nutrition · doi:10.1093/jn/138.4.698 · Cited by 147 · see citing works

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Ørskov, C., Rabenhøj, L., Wettergren, A., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.4.535 · Cited by 143 · see citing works

Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system

Gustafson, E. L., Smith, K. E., Durkin, M. M., Walker, M. W., Gerald, C., Weinshank, R. L., & Branchek, T. A. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00017-x · Cited by 140 · see citing works

Peptide YY (PYY), a poteny orexigenic agent

Morley, J. E., Levine, A. S., Grace, M. K., & Kneip, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)91490-8 · Cited by 137 · see citing works

Effect of Macronutrient Composition on Postprandial Peptide YY Levels

Essah, P. A., Levy, J. R., Sistrun, S. N., Kelly, S. M., & Nestler, J. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2273 · Cited by 133 · see citing works

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin

Riddle, M. C., Henry, R. R., Poon, T., Bei, Z., Mac, S. M., Holcombe, J. H., Kim, D. D. H., & Maggs, D. G. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.646 · Cited by 126 · see citing works

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

Thorens, B., Porret, A., Buhler, L., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.11.1678 · Cited by 126 · see citing works

Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.

Dumont, Y., Fournier, A., St-Pierre, S. A., & Quirion, R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24459-7 · Cited by 125 · see citing works

Eating for pleasure or calories

Zheng, H., & Berthoud, H. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.011 · Cited by 116 · see citing works

The neurocognitive bases of human multimodal food perception: Consciousness

Verhagen, J. V. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.002 · Cited by 109 · see citing works

Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects

Steinert, R. E., Poller, B., Castelli, M., Drewe, J., & Beglinger, C. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29663 · Cited by 93 · see citing works

PYY(3–36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats

Blevins, J. E., Chelikani, P. K., Haver, A. C., & Reidelberger, R. D. (2007) · Peptides · doi:10.1016/j.peptides.2007.11.003 · Cited by 71 · see citing works

Variation of Postprandial PYY3–36Response following Ingestion of Differing Macronutrient Meals in Obese Females

Helou, N., Obeid, O., Azar, S. T., & Hwalla, N. C. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000138122 · Cited by 68 · see citing works

GPR119: “Double-Dipping” for Better Glycemic Control

Lauffer, L., Iakoubov, R., & Brubaker, P. L. (2008) · Endocrinology · doi:10.1210/en.2008-0182 · Cited by 55 · see citing works

Molecular Forms of Glucagon-Like Immunoreactivity in Porcine Intestine and Pancreas*

Ghatei, M. A., UTTENTHAL, L. O., Bryant, M. G., Christofides, N. D., MOODY, A. J., & Bloom, S. R. (1983) · Endocrinology · doi:10.1210/endo-112-3-917 · Cited by 52 · see citing works

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus

Shughrue, P. J. (1996) · Endocrinology · doi:10.1210/en.137.11.5159 · Cited by 49 · see citing works

Antiobesity Surgery in Sweden From 1980 to 2005

Marsk, R., Freedman, J., Tynelius, P., Rasmussen, F. E., & Näslund, E. B. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318189b0cf · Cited by 48 · see citing works

[Cellular localization, half-life, and secretion of peptide YY].

Lluı́s, F., Fujimura, M., Gómez, G., Salvá, J. A., Greeley, G. H., & Thompson, J. C. (1989) · PubMed · Cited by 18 · see citing works

A tasty morsel: the role of the dorsal vagal complex in the regulation of food intake and swallowing. Focus on “BDNF/TrkB signaling interacts with GABAergic system to inhibit rhythmic swallowing in the rat,” by Bariohay et al.

Bailey, E. F. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90701.2008 · Cited by 14 · see citing works

Untitled work

Matelli (1998) · doi:10.1002/(sici)1096-9861(19981221)402:3

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works

Short-chain fatty acids in control of body weight and insulin sensitivity

Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298 · see citing works

The role of microbial amino acid metabolism in host metabolism

Neis, E., Dejong, C., & Rensen, S. (2015) · Nutrients · doi:10.3390/nu7042930 · Cited by 920 · see citing works

The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health

Nogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917 · see citing works

Short chain fatty acids: Microbial metabolites for gut-brain axis signalling

O’Riordan, K. J., Collins, M., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G. A., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 742 · see citing works

Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine

Nilius, B., & SZALLASI, A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008268 · Cited by 504 · see citing works

Gut Bacteria and Neurotransmitters

Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482 · see citing works

Gut microbiota and the neuroendocrine system

Farzi, A., Fröhlich, E. E., & Holzer, P. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0600-5 · Cited by 478 · see citing works

The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease

Hays, K. E., Pfaffinger, J. M., & Ryznar, R. J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393270 · Cited by 498 · see citing works

The Role of the Gut Microbiota in Bile Acid Metabolism

Ramírez-Pérez, O., Cruz-Ramón, V., Chinchilla-López, P., & Méndez‐Sánchez, N. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5672 · Cited by 393 · see citing works

Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review

Dahiya, D. K., Renuka, Puniya, M., Shandilya, U. K., Dhewa, T., Kumar, N., Kumar, S., Puniya, A. K., & Shukla, P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00563 · Cited by 357 · see citing works

Probiotics, prebiotics, synbiotics and insulin sensitivity

Kim, Y. A., Keogh, J. B., & Clifton, P. M. (2017) · Nutrition Research Reviews · doi:10.1017/s095442241700018x · Cited by 341 · see citing works

Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice

Carvalho, B. M., Guadagnini, D., Tsukumo, D. M. L., Schenka, A. A., Latuf-Filho, P., Vassallo, J., Dias, J. C., Kubota, L. T., Carvalheira, J. B. C., & Saad, M. J. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2648-4 · Cited by 314 · see citing works

Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis

Schneider, E., O'Riordan, K. J., Clarke, G., & Cryan, J. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01108-6 · Cited by 258 · see citing works

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion

Polidori, D., Sha, S., Mudaliar, S. R. D., Ciaraldi, T. P., Ghosh, A., Vaccaro, N. M., Farrell, K., Rothenberg, P., & Henry, R. R. (2013) · Diabetes Care · doi:10.2337/dc12-2391 · Cited by 262 · see citing works

Altered gut and adipose tissue hormones in overweight and obese individuals: Cause or consequence?

Lean, M. E. J., & Malkova, D. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.220 · Cited by 253 · see citing works

Pharmacotherapy of obesity: available medications and drugs under investigation.

Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248 · see citing works

The critical role of gut microbiota in obesity

Cheng, Z., Zhang, L., Yang, L., & Chu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1025706 · Cited by 233 · see citing works

Tryptophan metabolites along the microbiota-Gut-Brain axis: an interkingdom communication system influencing the gut in health and disease

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920928984 · Cited by 221 · see citing works

Mechanisms Linking the Gut Microbiome and Glucose Metabolism

Utzschneider, K. M., Kratz, M., Damman, C. J., & Hullarg, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4251 · Cited by 223 · see citing works

Dietary fiber in the prevention of obesity and obesity-related chronic diseases: From epidemiological evidence to potential molecular mechanisms

Waddell, I. S., & Orfila, C. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2061909 · Cited by 211 · see citing works

Severe Acute Malnutrition in Childhood: Hormonal and Metabolic Status at Presentation, Response to Treatment, and Predictors of Mortality

Bartz, S., Mody, A., Hornik, C. P. V., Bain, J. R., Muehlbauer, M. J., Kiyimba, T., Kiboneka, E., Stevens, R., Bartlett, J. A., Peter, J. V. S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4018 · Cited by 195 · see citing works

Current applications, selection, and possible mechanisms of actions of synbiotics in improving the growth and health status in aquaculture: A review

Huynh, T.-G., Shiu, Y., Nguyen, T.-P., Truong, Q.-P., Chen, J.-C., & Liu, C. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.03.035 · Cited by 200 · see citing works

Beneficial Effects of Dietary Polyphenols on High-Fat Diet-Induced Obesity Linking with Modulation of Gut Microbiota

Liu, J., He, Z., Ma, N., & Chen, Z. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06817 · Cited by 195 · see citing works

GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity

Kadouh, H., Chedid, V., Halawi, H., Burton, D. D., Clark, M. M., Khemani, D., Vella, A., Acosta, A., & Camilleri, M. (2020) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/clinem/dgz140 · Cited by 166 · see citing works

Hypoglycemic and Hypolipidemic Mechanism of Tea Polysaccharides on Type 2 Diabetic Rats via Gut Microbiota and Metabolism Alteration

Li, H., Fang, Q., Nie, Q., Hu, J., Yang, C., Huang, T., Li, H., & Nie, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01968 · Cited by 163 · see citing works

The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier

Wei, T., Zhu, H., Feng, Y., Guo, R., & Wan, D. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s254403 · Cited by 163 · see citing works

Late endocrine effects of childhood cancer

Rose, S. R., Horne, V. E., Howell, J. C., Lawson, S. A., Rutter, M. M., Trotman, G. E., & Corathers, S. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.45 · Cited by 154 · see citing works

Effects of polysaccharides on glycometabolism based on gut microbiota alteration

Fang, Q., Hu, J., Nie, Q., & Nie, S. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.08.015 · Cited by 155 · see citing works

Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM)

Ponzo, V., Fedele, D., Goitre, I., Leone, F., Lezo, A., Monzeglio, C., Finocchiaro, C., Ghigo, E., & Bo, S. (2019) · Nutrients · doi:10.3390/nu11020330 · Cited by 155 · see citing works

Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men

Schmidt, J. B., Gregersen, N. T., Pedersen, S. D., Arentoft, J. L., Ritz, C., Schwartz, T. W., Holst, J. J., Astrup, A. V., & Sjödin, A. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00569.2013 · Cited by 147 · see citing works

Weight Regain After Gastric Bypass: Influence of Gut Hormones

Santo, M. A., Riccioppo, D., Pajecki, D., Kawamoto, F., de Cleva, R., Antonangelo, L., Marçal, L., & Cecconello, I. (2016) · Obesity Surgery · doi:10.1007/s11695-015-1908-z · Cited by 145 · see citing works

Gut Microbiota: A Perspective for Psychiatrists

Rea, K., Dinan, T. G., & Cryan, J. F. (2019) · Neuropsychobiology · doi:10.1159/000504495 · Cited by 142 · see citing works

Gastrointestinal changes after bariatric surgery

Quercia, I., Dutia, R., Kotler, D. P., Belsley, S., & Laferrère, B. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.11.003 · Cited by 140 · see citing works

Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity

Jena, P. K., Sheng, L., Di Lucente, J., Jin, L., Maezawa, I., & Wan, Y. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201700984rr · Cited by 134 · see citing works

Gut–X axis

Xu, L., Zhang, Y., Li, X., Li, C., Hu, H., Hu, J., Liu, M., Yang, Q. Z., Gu, P., Li, J., et al. (2025) · iMeta · doi:10.1002/imt2.270 · Cited by 138 · see citing works

Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S

Bala, V., Rajagopal, S., Kumar, D. P., Nalli, A. D., Mahavadi, S., Sanyal, A. J., Grider, J. R., & Murthy, K. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00420 · Cited by 124 · see citing works

Propionate-Producing Consortium Restores Antibiotic-Induced Dysbiosis in a Dynamic in vitro Model of the Human Intestinal Microbial Ecosystem

Hage, R. E., Hernandez‐Sanabria, E., Calatayud, M., Props, R., & de Wiele, T. V. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01206 · Cited by 120 · see citing works

Adzuki Bean Alleviates Obesity and Insulin Resistance Induced by a High-Fat Diet and Modulates Gut Microbiota in Mice

Zhao, Q., Hou, D., Fu, Y., Xue, Y., Guan, X., & Shen, Q. (2021) · Nutrients · doi:10.3390/nu13093240 · Cited by 110 · see citing works

Mechanisms underlying current and future anti-obesity drugs

Adan, R. A. H. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.001 · Cited by 106 · see citing works

Gut Microbiota: A Contributing Factor to Obesity

Harakeh, S., Khan, I., Kumosani, T. A., Barbour, E. K., Almasaudi, S. B., Bahijri, S., Alfadul, S. M., Ajabnoor, G., & Azhar, E. I. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00095 · Cited by 106 · see citing works

Synthesis and Functions of Resistant Starch

Wang, Z., Wang, S., Xu, Q., Kong, Q., Li, F., Lin, L., Xu, Y., & Wei, Y. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.06.001 · Cited by 106 · see citing works

Dairy Foods and Dairy Proteins in the Management of Type 2 Diabetes: A Systematic Review of the Clinical Evidence

Pasin, G., & Comerford, K. B. (2015) · Advances in Nutrition · doi:10.3945/an.114.007690 · Cited by 104 · see citing works

Gut microbiota as an “invisible organ” that modulates the function of drugs

Li, X., Liu, L., Cao, Z., Li, W., Li, H., Lu, C. C., Yang, X., & Liu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109653 · Cited by 107 · see citing works

Obesity Affects the Microbiota–Gut–Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators

Forte, N. R., Fernández-Rilo, A. C., Palomba, L., Marzo, V. D., & Cristino, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051554 · Cited by 104 · see citing works

Motilin-induced gastric contractions signal hunger in man

Tack, J. F., Deloose, E., Ang, D., Scarpellini, E., Vanuytsel, T., Oudenhove, L. V., & Depoortere, I. (2014) · Gut · doi:10.1136/gutjnl-2014-308472 · Cited by 99 · see citing works

Effects of Dietary Fibre (Pectin) and/or Increased Protein (Casein or Pea) on Satiety, Body Weight, Adiposity and Caecal Fermentation in High Fat Diet-Induced Obese Rats

Adam, C. L., Gratz, S. W., Peinado, D. I., Thomson, L. M., Garden, K. E., Williams, P. A. H., Richardson, A. J., & Ross, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155871 · Cited by 93 · see citing works

Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats

Sun, H., Wang, N., Cang, Z., Zhu, C., Zhao, L., Nie, X., Cheng, J., Xia, F., Zhai, H., & Lu, Y. (2016) · Obesity Facts · doi:10.1159/000449507 · Cited by 90 · see citing works

Gut-Brain Axis in the Early Postnatal Years of Life: A Developmental Perspective

Jena, A., Montoya, C. A., Mullaney, J. A., Dilger, R. N., Young, W., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00044 · Cited by 92 · see citing works

Interactions between the microbiota and enteric nervous system during gut-brain disorders

Fried, S. G., Wemelle, E., Cani, P. D., & Knauf, C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108721 · Cited by 90 · see citing works

The microbiota-gut-brain axis: Focus on the fundamental communication pathways

Bistoletti, M., Bosi, A., Banfi, D., Giaroni, C., & Baj, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 88 · see citing works

A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes

Guess, N. D., Dornhorst, A., Oliver, N. S., Bell, J. D., Thomas, E. L., & Frost, G. S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0033-2 · Cited by 90 · see citing works

Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11–14.5 hour perspective; a randomized controlled study in healthy subjects

Sandberg, J. C., Björck, I., & Nilsson, A. C. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0246-5 · Cited by 87 · see citing works

Leveraging the Gut to Treat Metabolic Disease

Gimeno, R. E., Briere, D. A., & Seeley, R. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.014 · Cited by 82 · see citing works

The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention

Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 81 · see citing works

The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases

Münte, E., & Hartmann, P. (2025) · Biomolecules · doi:10.3390/biom15040469 · Cited by 83 · see citing works

A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?

Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75 · see citing works

Factors affecting circulating levels of peptide YY in humans: a comprehensive review

Cooper, J. A. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000109 · Cited by 73 · see citing works

Oral administration of protein nanoparticles: An emerging route to disease treatment

Sadeghi, S., Lee, W. K., Kong, S. N., Shetty, A., & Drum, C. L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104685 · Cited by 73 · see citing works

Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells

Billing, L., Smith, C. A., Larraufie, P., Goldspink, D. A., Galvin, S. G., Kay, R. G., Howe, J. D., Walker, R., Pruna, M., Glasssmith, L. L., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.011 · Cited by 72 · see citing works

Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity

Kumar, U., & Singh, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072568 · Cited by 72 · see citing works

Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System

Chandramowlishwaran, P., Vijay, A., Abraham, D., Li, G., Mwangi, S. M., & Srinivasan, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614331 · Cited by 74 · see citing works

When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies

Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 74 · see citing works

Whole Grain Oats Improve Insulin Sensitivity and Plasma Cholesterol Profile and Modify Gut Microbiota Composition in C57BL/6J Mice

Zhou, A. L., Hergert, N., Rompato, G., & Lefevre, M. (2014) · Journal of Nutrition · doi:10.3945/jn.114.199778 · Cited by 71 · see citing works

The Influence of the Gut Microbiota on Host Physiology: In Pursuit of Mechanisms.

Jones, R. M. (2016) · PubMed Central · Cited by 70 · see citing works

The mechanism of berberine alleviating metabolic disorder based on gut microbiome

Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69 · see citing works

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior

Samms, R. J., Cosgrove, R., Snider, B. M., Furber, E. C., Droz, B. A., Briere, D. A., Dunbar, J. D., Dogra, M., Alsina‐Fernandez, J., Borner, T., et al. (2022) · Diabetes · doi:10.2337/db21-0848 · Cited by 69 · see citing works

Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity

Gan, H., Cerbone, M., & Dattani, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 71 · see citing works

Role of ghrelin in the pathophysiology of gastrointestinal disease

Cheung, C. K., & Wu, J. C.-Y. (2013) · Gut and Liver · doi:10.5009/gnl.2013.7.5.505 · Cited by 68 · see citing works

Metabolic Effects of Resistant Starch Type 2: A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials

Snelson, M., Jong, J., Manolas, D., Kok, S., Louise, A., Stern, R., & Kellow, N. J. (2019) · Nutrients · doi:10.3390/nu11081833 · Cited by 68 · see citing works

Dietary Management of Obesity: A Review of the Evidence

Hwalla, N., & Jaafar, Z. (2020) · Diagnostics · doi:10.3390/diagnostics11010024 · Cited by 66 · see citing works

Chrononutrition—When We Eat Is of the Essence in Tackling Obesity

Ahluwalia, M. K. (2022) · Nutrients · doi:10.3390/nu14235080 · Cited by 72 · see citing works

Our Mental Health Is Determined by an Intrinsic Interplay between the Central Nervous System, Enteric Nerves, and Gut Microbiota

Dicks, L. M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010038 · Cited by 66 · see citing works

Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites

Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 69 · see citing works

Exercise-Trained Men and Women: Role of Exercise and Diet on Appetite and Energy Intake

Howe, S. M., Hand, T. M., & Manore, M. M. (2014) · Nutrients · doi:10.3390/nu6114935 · Cited by 62 · see citing works

Changes in hunger and fullness in relation to gut peptides before and after 8 weeks of alternate day fasting

Hoddy, K. K., Gibbons, C., Kroeger, C. M., Trepanowski, J. F., Barnosky, A., Bhutani, S., Gabel, K., Finlayson, G., & Varady, K. A. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.011 · Cited by 60 · see citing works

Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals

Wölnerhanssen, B. K., Moran, A. W., Burdyga, G., Meyer‐Gerspach, A. C., Peterli, R., Manz, M., Thumshirn, M., Daly, K., Beglinger, C., & Shirazi‐Beechey, S. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08487-9 · Cited by 56 · see citing works

Treating binge eating and food addiction symptoms with low-carbohydrate Ketogenic diets: a case series

Carmen, M., Safer, D. L., Saslow, L. R., Kalayjian, T., Mason, A. E., Westman, E. C., & Sethi, S. (2020) · Journal of Eating Disorders · doi:10.1186/s40337-020-0278-7 · Cited by 57 · see citing works

Dietary lipids with potential to affect satiety: Mechanisms and evidence

Maher, T., & Clegg, M. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1423277 · Cited by 59 · see citing works

Sotagliflozin: a dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor for the management of Type 1 and Type 2 diabetes mellitus

Sims, H., Smith, K. H., Bramlage, P., & Minguet, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13645 · Cited by 53 · see citing works

Ileostomy diarrhea: Pathophysiology and management

Rowe, K. M., & Schiller, L. R. (2020) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2020.1712926 · Cited by 51 · see citing works

Clinical Trials of Probiotic Strains in Selected Disease Entities

Dudek-Wicher, R. K., Junka, A., Paleczny, J., & Bartoszewicz, M. (2020) · International Journal of Microbiology · doi:10.1155/2020/8854119 · Cited by 53 · see citing works

Gut Microbiome Regulation of Gut Hormone Secretion

Chao, J. L., Coleman, R. A., Keating, D. J., & Martin, A. M. (2025) · Endocrinology · doi:10.1210/endocr/bqaf004 · Cited by 54 · see citing works

Tryptophan and Its Metabolite Serotonin Impact Metabolic and Mental Disorders via the Brain–Gut–Microbiome Axis: A Focus on Sex Differences

Xu, M., Zhou, E. Y., & Shi, H. (2025) · Cells · doi:10.3390/cells14050384 · Cited by 55 · see citing works

Gut Hormones and Regulation of Food Intake in Birds

Honda, K., Saneyasu, T., & Kamisoyama, H. (2016) · The Journal of Poultry Science · doi:10.2141/jpsa.0160100 · Cited by 50 · see citing works

Metabolomics in Nutrition Research: Biomarkers Predicting Mortality in Children with Severe Acute Malnutrition

Freemark, M. (2015) · Food and Nutrition Bulletin · doi:10.1177/15648265150361s114 · Cited by 50 · see citing works

Effect of Sodium Glucose Cotransporter 2 Inhibitors With Low SGLT2/SGLT1 Selectivity on Circulating Glucagon-Like Peptide 1 Levels in Type 2 Diabetes Mellitus

Takebayashi, K., & Inukai, T. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3112w · Cited by 49 · see citing works

Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters

Guo, H., Ma, C., Zheng, W., Luo, Y., Li, C., Li, X., Ma, X., Feng, C., Zhang, T., Han, Y., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201808197 · Cited by 48 · see citing works

Genetic contributions to the etiology of anorexia nervosa: new perspectives in molecular diagnosis and treatment

Paolacci, S., Kiani, A. K., Manara, E., Beccari, T., Ceccarini, M. R., Stuppia, L., Chiurazzi, P., Dalla Ragione, L., & Bertelli, M. (2020) · Molecular Genetics &amp; Genomic Medicine · doi:10.1002/mgg3.1244 · Cited by 47 · see citing works

Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity

Cunningham, A., Stephens, J. W., & Harris, D. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00858-4 · Cited by 48 · see citing works

Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction

Lee, B., Lee, S. M., Song, J. W., & Choi, J. W. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.009 · Cited by 48 · see citing works

A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial

Pinheiro, I., Robinson, L. E., Verhelst, A., Marzorati, M., Winkens, B., den Abbeele, P. V., & Possemiers, S. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1948-0 · Cited by 49 · see citing works

Dairy-derived peptides for satiety

Kondrashina, A. V., Brodkorb, A., & Giblin, L. M. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103801 · Cited by 47 · see citing works

Effects of dietary fibers with different fermentation characteristics on feeding motivation in adult female pigs

da Silva, C. S., Bolhuis, J. E., Gerrits, W. J. J., Kemp, B., & van den Borne, J. J. G. C. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.01.006 · Cited by 46 · see citing works

Understanding the interplay between food structure, intestinal bacterial fermentation and appetite control

Dagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44 · see citing works

The Effect of Lipidation on the Self-Assembly of the Gut-Derived Peptide Hormone PYY 3–36

Hutchinson, J. A., Burholt, S., Hamley, I. W., Lundbäck, A.-K., Uddin, S., dos Santos, A. G., Reza, M., Seitsonen, J. J. T., & Ruokolainen, J. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00286 · Cited by 44 · see citing works

Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions

Săvulescu-Fiedler, I., Benea, S. N., Căruntu, C., Nancoff, A.-S., Homentcovschi, C., & Bucurica, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070489 · Cited by 45 · see citing works

The intestinal microbiota, energy balance, and malnutrition: emphasis on the role of short-chain fatty acids

Fluitman, K. S., de Clercq, N. C., Keijser, B. J. F., Visser, M., Nieuwdorp, M., & IJzerman, R. G. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1318060 · Cited by 44 · see citing works

Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells

Han, Y. E., Kang, C. W., Oh, J. H., Park, S. H., Ku, C. R., Cho, Y. H., Lee, M. K., & Lee, E. J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00165 · Cited by 43 · see citing works

Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation

Xie, H., Yepuri, N., Meng, Q., Dhawan, R., Leech, C. A., Chepurny, O., Holz, G. G., & Cooney, R. (2020) · Reviews in Endocrine & Metabolic Disorders · doi:10.1007/s11154-020-09584-3 · Cited by 37 · see citing works

review Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Silva, A. D., & Bloom, S. R. (2013)

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · see citing works

A medical bypass. Can the manipulation of gut hormone levels replicate the favourable effects on energy and glucose homeostasis seen following gastric bypass surgery?

Troke, R. (2016) · doi:10.25560/47922

Gut Hormones as Peripheral Anti Obesity Targets

Small, C. J., & Bloom, S. R. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043336950 · Cited by 50 · see citing works

Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery

Svane, M. S., Jørgensen, N. B., Bojsen-Møller, K. N., Dirksen, C., Nielsen, S., Kristiansen, V. B., Toräng, S., Wewer Albrechtsen, N. J., Rehfeld, J. F., Hartmann, B., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.121 · Cited by 185 · see citing works